Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine

ClinicalTrials.gov ID: NCT02974153

Public ClinicalTrials.gov record NCT02974153. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Chronic Migraine

Study identification

NCT ID
NCT02974153
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alder Biopharmaceuticals, Inc.
Industry
Enrollment
1,121 participants

Conditions and interventions

Interventions

  • ALD403 (Eptinezumab) Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2016
Primary completion
Oct 31, 2017
Completion
Mar 31, 2018
Last update posted
Jun 8, 2020

2016 – 2018

United States locations

U.S. sites
74
U.S. states
34
U.S. cities
68
Facility City State ZIP Site status
Research Site Birmingham Alabama 35235
Research Site Phoenix Arizona 85032
Research Site Little Rock Arkansas 72211
Research Site Carlsbad California 92011
Research Site Oceanside California 92056
Research Site Orange California 92868
Research Site Oxnard California 93030
Research Site Palo Alto California 94304
Research Site Redlands California 92374
Research Site San Diego California 92108
Research Site Santa Monica California 90404
Research Site Torrance California 90502
Research Site Colorado Springs Colorado 80918
Research Site New London Connecticut 06320
Research Site Jacksonville Florida 32256
Research Site Miami Florida 33155
Research Site Orlando Florida 32806
Research Site Tampa Florida 33606
Research Site West Palm Beach Florida 33407
Research Site Winter Haven Florida 33880
Research Site Atlanta Georgia 30328
Research Site Atlanta Georgia 30342
Research Site Decatur Georgia 30030
Research Site Champaign Illinois 61820
Research Site Chicago Illinois 60607
Research Site Chicago Illinois 60642
Research Site Anderson Indiana 46011
Research Site Des Moines Iowa 50309
Research Site Overland Park Kansas 66212
Research Site Prairie Village Kansas 66208
Research Site Wichita Kansas 67207
Research Site Marrero Louisiana 70072
Research Site Waldorf Maryland 20603
Research Site Boston Massachusetts 02135
Research Site North Attleboro Massachusetts 02740
Research Site Watertown Massachusetts 02472
Research Site Ann Arbor Michigan 48104
Research Site Minneapolis Minnesota 55402
Research Site Flowood Mississippi 39232
Research Site City of Saint Peters Missouri 63303
Research Site Springfield Missouri 65810
Research Site St Louis Missouri 63141
Research Site Las Vegas Nevada 89113
Research Site Lebanon New Hampshire 03756
Research Site Princeton New Jersey 08540
Research Site Albuquerque New Mexico 87102
Research Site Amherst New York 14226
Research Site Brooklyn New York 11229
Research Site New York New York 10016
Research Site New York New York 10019
Research Site Plainview New York 11803
Research Site Rochester New York 14609
Research Site Durham North Carolina 27705
Research Site High Point North Carolina 27262
Research Site Canton Ohio 44718
Research Site Dayton Ohio 45432
Research Site Oklahoma City Oklahoma 73116
Research Site Scottdale Pennsylvania 15683
Research Site Smithfield Pennsylvania 15478
Research Site Mt. Pleasant South Carolina 29464
Research Site Chattanooga Tennessee 37404
Research Site Chattanooga Tennessee 37421
Research Site Memphis Tennessee 38119
Research Site Nashville Tennessee 37203
Research Site Dallas Texas 75214
Research Site Houston Texas 77058
Research Site Houston Texas 77081
Research Site North Richland Hills Texas 76180
Research Site San Antonio Texas 78258
Research Site Salt Lake City Utah 84109
Research Site Salt Lake City Utah 84123
Research Site Richmond Virginia 23294
Research Site Bellevue Washington 98007
Research Site Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02974153, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 8, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02974153 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →